Skip to main content
Ken Takeshita, MD, Hematology, New York, NY

KenTakeshitaMD

Hematology New York, NY

Physician

Dr. Takeshita is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Takeshita's full profile

Already have an account?

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1986 - 1988
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1984 - 1986
  • Yale School of Medicine
    Yale School of MedicineClass of 1983

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1994 - 2026
  • CT State Medical License
    CT State Medical License 1986 - 1995
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Press Mentions

  • AstraZeneca Enhertu Granted Priority Review in US for Metastatic HER2-Positive Solid Tumours
    AstraZeneca Enhertu Granted Priority Review in US for Metastatic HER2-Positive Solid TumoursJanuary 31st, 2024
  • AstraZeneca’s Dato-DXd Significantly Improved PFS in Lung Cancer
    AstraZeneca’s Dato-DXd Significantly Improved PFS in Lung CancerJuly 3rd, 2023
  • Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast Cancer
    Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast CancerMarch 4th, 2024
  • Join now to see all

Professional Memberships